Testosterone therapy without clear evidence of symptomatic deficiency may be linked to higher long-term cardiovascular risk.
“Nevertheless, the results reinforce confirming hypogonadism and reviewing cardiovascular risk with a clinician before starting testosterone therapy. In Aliquot #116, I discuss strategies to optimize testosterone levels.”